Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017).

Overview of attention for article published in Journal of Clinical Psychiatry, May 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 1 X user

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 news story.

Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry

The Standard-Journal, 18 Jun 2024

CORAL GABLES, Fla., June 18, 2024 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.